Company Info
Phone(919) 550-2200
Year Established
1993
Ticker
NVO
Exchange
NYSE
Contacts
Doug LangaPresident
Steve Benz
General Counsel
Ulrich Otte
Senior VP, Finance & Operations
Steve Albers
Senior VP, Market Access & Public Affairs
Blandine Lacroix
Senior VP, BioPharm & Strategy
Jill Fallows Macaluso
VP, Chief Compliance Officer
Company Description
Novo Nordisk Pharmaceutical Industries manufactures insulin products for individuals with diabetes. The products manufactured at the Clayton plant are marketed in North America, Europe, New Zealand and Australia.
